EUVIMEDEUVIMED entdecken
Crossref

A novel and fast 3D dosimetry for patient-specific quality assurance in proton therapy

Faming Luo iD, Qi Liu iD, Xinle Lang iD, Zhengguo Hu iD, Juan Li iD, Xincai Kang iD, Zulong Zhao iD, Pengyuan Qi iD, Jing Yang, Ruishi Mao iD, Guoqing Xiao, Lian Zhang und 2 weitere

Physics in Medicine & Biology · 2026

DOI: 10.1088/1361-6560/ae2aa5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physics in Medicine & Biology, 2026. Verfasst von Faming Luo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, People's Republic of China. Hauptthemen laut MEDLINE: Proton Therapy, Radiometry, Quality Assurance, Health Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Scientific Instrument Developing Project of the Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective. In clinical proton therapy, patient-specific quality assurance (PSQA) is typically performed by using two-dimensional (2D) array detectors placed at two or three selected depths within a phantom. While this method is effective for basic verification, it lacks comprehensive spatial coverage and may miss dose delivery errors in the region with steep dose gradients. This study aims to develop and validate a novel three-dimensional (3D) dosimetry system (PlanDOSE) for full volumetric dose reconstruction from a single treatment delivery, improving the efficiency and accuracy of PSQA in pencil beam scanning (PBS) proton therapy. Approach. PlanDOSE reconstructs 3D dose distributions by real-time monitoring the proton pencil beam using a multi-layer ionization chamber (MLIC) and an integrated dose-position monitoring system (IDPMS). The system was calibrated in detail prior to use, including absolute monitor unit (MU) response, relative channel sensitivity, and water-equivalent thickness (WET) calibration. Its performance was evaluated for multiple intensity modulated proton therapy plans of varying complexities, which includes three standard proton cubes and three clinical plans (brain, lung, liver). Dose distributions reconstructed by PlanDOSE were compared with Eclipse treatment planning system calculations using gamma analysis (2 mm/2%, 10% threshold). Main results. Calibration results showed that PlanDOSE achieved absolute MU measurement errors within ±1%, and inter-channel correction significantly improved the response consistency of MLIC. WET calibration enabled accurate depth-dose curve measurements, with average errors between −1.07% and 2.34%. In dose reconstruction validation, PlanDOSE achieved average gamma passing rates of 98.53% for lateral, 95.40% for depth, and 96.85% for 3D dose distributions. Compared to traditional 2D-based QA dosimetry, PlanDOSE demonstrated higher spatial resolution and better dose fidelity, particularly in regions with steep gradients. Significance. PlanDOSE enables accurate, high-resolution 3D dose verification from a single treatment delivery, offering a more efficient and clinically informative alternative to conventional QA methods, and shows great potential for routine use in PSQA for PBS proton therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton TherapyRadiometryQuality Assurance, Health CareHumansRadiotherapy Planning, Computer-AssistedTime FactorsRadiotherapy DosagePhantoms, ImagingCalibrationQuality Control

Stichwörter der Autor:innen

pencil beam scanningproton therapyquality assurancethree-dimensional dose verification

Autor:innen und Institutionen

  • Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, People's Republic of China.
  • School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Medical Artificial Intelligence Lab, The First Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Hebei Provincial Engineering Research Center for AI-Based Cancer Treatment Decision-Making, The First Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Department of Oncology, The First Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, People's Republic of China.

ORCID-Profile: Faming Luo, Qi Liu, Xinle Lang, Zhengguo Hu, Juan Li, Xincai Kang, Zulong Zhao, Pengyuan Qi, Ruishi Mao, Zhiguo Xu, Zhiyong Yang

Förderung

  • Scientific Instrument Developing Project of the Chinese Academy of Sciences

Zitieren

APA

Luo, F., Liu, Q., Lang, X., Hu, Z., Li, J., Kang, X., Zhao, Z., Qi, P., Yang, J., Mao, R., Xiao, G., Zhang, L., Xu, Z., & Yang, Z. (2026). A novel and fast 3D dosimetry for patient-specific quality assurance in proton therapy. Physics in Medicine & Biology. https://doi.org/10.1088/1361-6560/ae2aa5

Vancouver

Luo F, Liu Q, Lang X, Hu Z, Li J, Kang X, et al. A novel and fast 3D dosimetry for patient-specific quality assurance in proton therapy. Physics in Medicine & Biology. 2026. doi:10.1088/1361-6560/ae2aa5

BibTeX
@article{Luo2026,
  author = {Luo, Faming and Liu, Qi and Lang, Xinle and Hu, Zhengguo and Li, Juan and Kang, Xincai and Zhao, Zulong and Qi, Pengyuan and Yang, Jing and Mao, Ruishi and Xiao, Guoqing and Zhang, Lian and Xu, Zhiguo and Yang, Zhiyong},
  title = {A novel and fast 3D dosimetry for patient-specific quality assurance in proton therapy},
  journal = {Physics in Medicine & Biology},
  year = {2026},
  doi = {10.1088/1361-6560/ae2aa5}
}
Kostenlos starten →